Download - Baseline
Transcript
![Page 1: Baseline](https://reader037.vdocument.in/reader037/viewer/2022110100/56812a52550346895d8d9eff/html5/thumbnails/1.jpg)
A
Baseline On-treatment
56% decrease in pS6 staining
B30% decrease SUVmax in perihepatic disease
CCA125 Response Observed
A
Baseline On-treatment
56% decrease in pS6 staining
B30% decrease SUVmax in perihepatic disease
CCA125 Response Observed